9th Circ. Revives Hytrin Saga

Law360, New York (January 14, 2009, 12:00 AM EST) -- The U.S. Court of Appeals for the Ninth Circuit has breathed new life into the long-standing antitrust case over the Hytrin settlement, remanding a portion of the suit for further proceedings after a decade of litigation over the hypertension drug.

On Tuesday, the Ninth Circuit tossed out a Florida court's summary judgment ruling against Kaiser Foundation Health Plan Inc., ruling that Abbott Laboratories' supposed violation of Section Two of the Sherman Act merited further scrutiny.

“We agree with the multidistrict litigation court’s conclusion that Kaiser has...
To view the full article, register now.